Recent advances in triple negative breast cancer: the immunotherapy era

Several accomplishments have been achieved in triple-negative breast cancer (TNBC) research over the last year. The phase III IMpassion130 trial comparing chemotherapy plus atezolizumab versus chemotherapy plu…

Leave a Reply

Your email address will not be published. Required fields are marked *